肿瘤微环境影响乳腺癌耐药蛋白转录调控的研究进展
被引量:1
摘要
乳腺癌耐药蛋白(breast cancer resistance protein,BCRP)是ABC转运蛋白超家族G亚家族重要成员之一。
出处
《浙江医学》
CAS
2013年第22期2039-2040,共2页
Zhejiang Medical Journal
基金
嘉兴市科技计划项目(2010AY1033)
二级参考文献3
-
1Yan Wang,Haining Peng,Yingli Zhong,Daiqiang Li,Mi Tang,Xiaofeng Ding,Jian Zhang.Differential gene expression profiling of human epidermal growth factor receptor 2- overexpressing mammary tumor[J].Acta Biochimica et Biophysica Sinica,2008,40(5):397-405. 被引量:1
-
2Nana Ji,Jianhui Yuan,Jianjun Liu,Shengli Tian.Developing multidrug-resistant cells and exploring correlation between BCRP/ABCG2 over-expression and DNA methyltransferase[J].Acta Biochimica et Biophysica Sinica,2010,42(12):854-862. 被引量:4
-
3Yaxin Zhao,Jiefan Liu,Qi Hong,Chen Yang,Li Chen,Ying Chen,Qiaoqiao Wang,Kuaile Zhao,Wei Jin.Involvement of MyoD and PEA3 in regulation of transcription activity of MDR1 gene[J].Acta Biochimica et Biophysica Sinica,2010,42(12):900-907. 被引量:3
共引文献7
-
1吴新刚,彭姝彬,黄谦.乳腺癌耐药蛋白基因的转录调控机制[J].遗传,2012,34(12):1529-1536. 被引量:9
-
2张小彦,沈珊珊,邹晓平.ABCG2和NF-κB在结直肠癌的表达[J].江苏医药,2013,39(23):2823-2826. 被引量:3
-
3杨宁,惠莲,杨会军,姜学钧.SOX2在5-氟尿嘧啶处理的人喉癌Hep-2细胞中的表达及作用机制[J].中国医科大学学报,2014,43(3):247-251. 被引量:1
-
4余文发,赵玉林,王萍,马慧敏,张国正,鲁保才,董明敏.siRNA沉默C-erbB-2基因对人喉癌Hep-2细胞PI3K/Akt信号通路的影响[J].临床耳鼻咽喉头颈外科杂志,2014,28(12):894-897. 被引量:2
-
5王炜,刘星言,程小广,李涛.盐酸米托蒽醌通过PI3K途径诱导人鼻咽癌CNE-2细胞凋亡[J].现代肿瘤医学,2015,23(2):153-156. 被引量:5
-
6徐杰伟,慎华平,邱建,魏云海,王雁,严强.沉默MK基因增强肝癌Bel/Fu细胞对5-氟尿嘧啶的敏感性及可能的机制[J].肿瘤,2017,37(12):1260-1267. 被引量:1
-
7孔祥云,何芸,赵明星,张俊.三甲氧基二苯乙烯增加胃癌细胞对顺铂敏感性的实验研究[J].中国医药生物技术,2017,12(6):532-538.
同被引文献17
-
1So WK, Marsh G, Ling WM, et al. The symptom cluster of fa- tigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multi- center study[J]. Oncol Nurs Forum, 2009,36(4) :E205-214.
-
2Bergamaschi A, Madak-EMogan Z, Kim Y, et al. The forkhead tin- scription factor FOXM1 promotes endocrine resistance and invasive- ness in estrogen receptor-positive breast cancer by expansion of stem- like cancer cells[J]. Breast Cancer Res, 2014,16(5) :436.
-
3Pelicano H, Zhang W, Liu J, et al. Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of roTOR path- way and therapeutic potential [ J ]. Breast Cancer Res, 2014, 16(5) :434.
-
4Miura D, Yoneymna K, Furuhata Y, et al. Paelitaxel enhances zaati- body-dependent cell-medialed eytotoxieity of trastuzumab by rapid re- cruitment of natural killer cells in HER2-positive breast earteer[J]. J Nippon Med Seh, 2014,81 (4) :211-220.
-
5Bjrneklett HG, Lindemalm C, Rosenblad A, et al. A randomised controlled trial of support group intervention after breast cancer treatment., results on inxiety and depression [ J ]. Acta Oncol, 2012,51 (2) :198-207.
-
6Ahem TP, Lash TL, Damkier P, et al. Statins and breast cancer prognosis: evidence and opportunities[ J]. Lancet Oncol, 2014, 15(10) :e461 468.
-
7Argov M, Kashi R, Peer D, et al. Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhancestherapeutic responses comparable to an aggressive bevaci- zumab regimen[ J]. Cancer Lett, 2009,274 ( 1 ) : 118-125.
-
8Kurzrock R, Gabrail N, Chandhasin C, et al. Safety, pharmacoki- neties, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paelitaxel, in patients with advanced solid tumors [ J]. Mol Cancer Ther, 2012,11 (2) : 308-316.
-
9Knramochi H, Tanaka K, Oh D, et al. Thymidylate syntbase poly- morphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients [ J ]. Int J Oncol, 2008,32( 1 ) :201-208.
-
10屈洪波,范原铭,韩明利,罗浩军,谢佳,刘红,刘毫,吴诚义,汤为学.化疗后残存乳腺癌组织中乳腺癌耐药蛋白、P-糖蛋白的表达及其与癌干细胞的相关性[J].中国医学科学院学报,2013,35(2):171-176. 被引量:27
二级引证文献9
-
1吴颖虹,王仁杰,朱少波,刘小景,张珏,江金梅.乳腺癌中MTDH的表达与淋巴结转移的关系[J].实验与检验医学,2015,33(5):596-597. 被引量:3
-
2崔剑锋.曲妥珠单抗联合长春瑞滨治疗HER-2阳性晚期乳腺癌患者的疗效分析[J].实用药物与临床,2017,20(7):759-762. 被引量:22
-
3宋强.托瑞米芬联合他莫昔芬治疗晚期乳腺癌的效果观察及对肝功能和血脂的影响[J].齐齐哈尔医学院学报,2017,38(15):1779-1781. 被引量:7
-
4虞宝中,贺汉军,侯艾林.来曲唑与他莫昔芬对绝经后乳腺癌切除术患者的治疗效果及其对子宫内膜厚度与子宫内膜病变的影响[J].中国医药,2017,12(10):1565-1568. 被引量:16
-
5远丽芳,陈俊林,王津京,马飞.乳腺癌化疗后中性粒细胞减少性发热的临床观察[J].北京医学,2017,39(11):1138-1141. 被引量:6
-
6梁法清,何阳君,杜正贵.乳腺癌疾病特征分析及应用托瑞米芬治疗进展[J].肿瘤药学,2018,8(2):139-142. 被引量:8
-
7董艳艳.晚期乳腺癌内分泌药物治疗效果观察[J].临床合理用药杂志,2019,12(31):80-81.
-
8司峻岭.为乳腺癌患者使用不同剂量的表柔比星进行化疗的效果对比[J].当代医药论丛,2020,18(6):156-157.
-
9常磊,卢雯平.基于数据挖掘探讨精准医学指导下乳腺癌分型论治的中医临床规律[J].中国医药,2022,17(3):340-344. 被引量:15
-
1杨成,王继见.乳腺癌耐药蛋白的研究进展[J].内分泌外科杂志,2008,2(2):127-130. 被引量:2
-
2李荣先,尚秀娟,吕保洲,刘莉,张波,文秀慧.肝硬化对大肠癌肝转移影响的观察[J].中国肛肠病杂志,2005,25(4):20-21.
-
3赵斌斌,朱运奎.肺癌转移中成纤维细胞的作用[J].现代肿瘤医学,2009,17(1):141-143. 被引量:1
-
4夏靖,于冬青,易永芬.多药耐药相关蛋白及其介导的肿瘤多药耐药[J].山东生物医学工程,2001,20(1):56-57.
-
5袁浩.正常基因与癌基因有差别吗?[J].生物学教学,1985,0(1):33-33.
-
6任香,舒春贵.HIF-1α和BCRP在乳腺浸润性导管癌组织中的表达及临床意义[J].中国癌症防治杂志,2014,6(3):289-291. 被引量:2
-
7JIAN-HUI YUAN,JIN-QUAN CHENG,LONG-YUAN JIANG,WEI-DONG JI,LIANG-FENG GUO,JIAN-JUN LIU,XING-YUN XU,JING-SONG HE,XIAN-MING WANG,ZHI-XIONG ZHUANG.Breast Cancer Resistance Protein Expression and 5-Fluorouracil Resistance[J].Biomedical and Environmental Sciences,2008,21(4):290-295. 被引量:5
-
8陈贵生.伊立替康用于晚期结肠癌患者临床效果观察[J].山东医药,2016,56(32):79-81. 被引量:5
-
9李毅平,别黎.常见肿瘤全基因组关联研究进展[J].中华临床医师杂志(电子版),2012,6(11). 被引量:2
-
10陈玉亚,郭勇.中医药干预对肿瘤微环境影响研究进展[J].辽宁中医药大学学报,2015,17(5):172-174. 被引量:1